Table 1.
Name of drug | Target | Phase of development |
---|---|---|
BCX9930 | Factor D | Phase II (NCT05162066) |
Eculizumab | C5 | Aborted |
Iptacopan (LNP023) | Factor B | Phase II (NCT04154787) |
Narsoplimab (OMS721) | MASP2 | Phase II (NCT02682407) |
Pegcetacoplan (APL-2) | C3, C3b | Aborted |